Burlingame, CA, United States of America

Fady Malik

This inventor holds 36 USPTO granted patents and 15 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Cardiac Therapies. Top assignees: Cytokinetics, Inc., Amgen Inc., Astellas Pharma Gmbh. Active years: 2002-2025.

USPTO Granted Patents = 36 (Patent Applications = 15)

% Patents Active = 80.6

CIPO Patents = 3 (Patent Applications = 8)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 4.4

ph-index = 11

Forward Citations = 392(Granted Patents)

Location History:

South San Francisco, CA (US) (2008 - 2023)
Burlingame, CA (US) (2002 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Heart Failure

Cardiac Sarcomere Activators

Tetrahydroisoquinoline Derivatives

Heterocyclic Sulfonamides

Skeletal Muscle Modulation

Congestive Heart Failure

Protein Modulators

Sarcomere Protein Composition

High Throughput Assay

Compositions and Methods

Omecamtiv Mecarbil

ALS Therapy

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12370179 - Methods for treating hypertrophic cardiomyopathy (2025-07-29),

2. 12295952 - Methods of treating heart failure with cardiac sarcomere activators (2025-05-13),

3. 12194039 - Methods of treating heart failure by administering omecamtiv mecarbil (2025-01-14),

4. 11986474 - Methods for treating heart failure by administering cardiac sarcomere activators (2024-05-21),

5. 11931358 - Methods of treating heart failure with cardiac sarcomere activators (2024-03-19),

6. 11576910 - Methods of treating heart failure with cardiac sarcomere activators (2023-02-14),

7. 11479561 - Tetrahydroisoquinoline derivatives (2022-10-25),

8. 10689393 - Tetrahydroisoquinoline derivatives (2020-06-23),

9. 10272082 - Combination ALS therapy (2019-04-30),

10. 10259821 - Tetrahydroisoquinoline derivatives (2019-04-16),

11. 9914741 - Tetrahydroisoquinoline derivatives (2018-03-13),

12. 8716291 - Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use (2014-05-06),

13. 8604025 - Heterocyclic sulfonamides (2013-12-10),

14. 8367661 - Heterocyclic sulfonamides (2013-02-05),

15. 8299248 - Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use (2012-10-30),

Title: The Innovative Journey of Fady Malik

Introduction: Fady Malik, a talented inventor based in Burlingame, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Fady Malik's latest patents include a cutting-edge artificial intelligence algorithm for predictive analytics and a revolutionary wearable device for monitoring vital signs in real-time.

Career Highlights: With a background in computer science and engineering, Fady Malik has worked for top tech companies in Silicon Valley, where he honed his skills in developing innovative solutions for complex problems.

Collaborations: Fady Malik has collaborated with leading research institutions and universities to further advance his inventions, showcasing his ability to work across multidisciplinary teams to achieve remarkable results.

Conclusion: Fady Malik's passion for pushing the boundaries of technology and his dedication to creating impactful inventions make him a standout figure in the world of innovation.